![](/img/cover-not-exists.png)
Rationale, design, and results from RENO-DEFEND 1: A randomized, dose-finding study of the selective A1 adenosine antagonist SLV320 in patients hospitalized with acute heart failure
Peter S. Pang, Mandeep Mehra, Aldo P. Maggioni, Gerasimos Filippatos, Jayne Middlebrooks, Prasad Turlapaty, Dmitri Kazei, Mihai GheorghiadeVolume:
161
Year:
2011
Language:
english
Pages:
65535
DOI:
10.1016/j.ahj.2011.03.004
File:
PDF, 278 KB
english, 2011